Opendata, web and dolomites

ILO SIGNED

Innovative dual cycle tracking system for contraception and conception on a single device

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ILO project word cloud

Explore the words cloud of the ILO project. It provides you a very rough idea of what is the project "ILO" about.

usually    child    pregnant    staff    opportunity    business    tool    carbomed    ilo    track    2023    temperature    women    relying    180    market    cutting    dual    none    conceiving    natural    influencing    measuring    app    innovative    accurate    predicts    irregular    health    precise    body    monitoring    core    first    wish    reaching    amount    overcome    strive    golden    fulfils    million    chances    combination    fairly    facts    invasive    fashioned    window    sell    stage    lack    criteria    expertise    cycle    hence    algorithms    accuracy    thanks    time    self    exhaled    variables    period    device    bespoke    stress    2016    scientifically    contraception    initially    progression    valued    500    edge    handheld    700    39    co2    count    rely    back    subjective    predicting    proven    ovulation    17    periods    units    length    menstrual    profits    conveys    approached    bleeding    air    manner    fertile    reliably    contraceptive    levels    tracking    cumulative    limitations    23    subsequently    commercialization    billion    seamlessly   

Project "ILO" data sheet

The following table provides information about the project.

Coordinator
CARBOMED MEDICAL SOLUTIONS GMBH & CO KG 

Organization address
address: NEUE STIFTINGTALSTRASSE 2/5 OG
city: GRAZ
postcode: 8010
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Austria [AT]
 Project website https://www.iloveovulation.com/en/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-05-01   to  2018-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CARBOMED MEDICAL SOLUTIONS GMBH & CO KG AT (GRAZ) coordinator 50˙000.00

Map

 Project objective

Women usually track their menstrual cycle for three main reasons: As a natural contraceptive tool, to increase the chances of conceiving or for health-related reasons. However, monitoring every stage of the cycle in an accurate manner has proven challenging, due to the many variables influencing its progression (e.g. irregular periods, stress, etc.). Currently, there are two main approached to cycle tracking: Cycle tracking devices (which represent the old-fashioned approach, fairly reliable but require self-assessment and expertise to get accuracy), and “cutting edge” app-based cycle tracking methods (which are user-friendly, but rely in subjective facts related to the period - e.g. length or amount of bleeding-, traditional measurements -e.g. core body temperature- and algorithms, and lack accuracy. Hence, none of these approaches fulfils the “golden” criteria of being reliable, precise, simple and non-invasive. At Carbomed, we strive to overcome the limitations of both approaches thanks to our innovative ILO system, the seamlessly combination of a handheld device and an app, that reliably predicts the time of ovulation by relying on a scientifically-based method: Measuring the CO2 levels from exhaled air. ILO conveys the best features from both approaches, being accurate, simple and non-invasive while providing a user-friendly experience thanks to our bespoke app. ILO can be used as a dual cycle tracking device predicting the most fertile window, as a natural contraceptive method, but also as a tracking device for those who want to get pregnant. For Carbomed, ILO represents a large business opportunity, aimed initially at the child wish market and subsequently (and most importantly) at the contraception market valued at €17.6 billion back in 2016. In this way, we expect to sell 180,500 ILO units in the first three years of commercialization, reaching cumulative profits of €23.39 million by 2023. To reach this goal, we will increase our staff count by 700%.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ILO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ILO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More  

Skye (2018)

Redefining Drone Safety and Autonomous Operation for Indoor Commercial Applications

Read More  

HUD (2018)

COMMERCIALIZING THE FIRST HEAD-UP-DISPLAY FOR OFF-HIGHWAY VEHICLES

Read More